Blue Fin Capital Inc. Raises Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Blue Fin Capital Inc. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,295 shares of the healthcare conglomerate’s stock after buying an additional 434 shares during the quarter. UnitedHealth Group accounts for about 2.1% of Blue Fin Capital Inc.’s portfolio, making the stock its 10th largest holding. Blue Fin Capital Inc.’s holdings in UnitedHealth Group were worth $8,052,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in UNH. Robbins Farley bought a new position in shares of UnitedHealth Group in the 3rd quarter valued at $25,000. Richelieu Gestion SA acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at about $26,000. CGC Financial Services LLC raised its holdings in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the last quarter. NewSquare Capital LLC increased its position in UnitedHealth Group by 340.0% in the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 51 shares during the period. Finally, LFA Lugano Financial Advisors SA lifted its holdings in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares during the period. 87.86% of the stock is owned by institutional investors.

Insider Activity

In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Barclays upped their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Royal Bank of Canada cut their target price on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. Cantor Fitzgerald restated an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Wednesday, April 10th. Piper Sandler increased their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Finally, Wells Fargo & Company cut their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Four analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

UnitedHealth Group Trading Down 0.1 %

UNH stock traded down $0.52 during trading on Friday, hitting $492.45. 2,487,811 shares of the company traded hands, compared to its average volume of 5,130,659. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The company has a 50-day moving average of $482.32 and a 200-day moving average of $512.76. The firm has a market capitalization of $453.09 billion, a PE ratio of 30.10, a P/E/G ratio of 1.43 and a beta of 0.55.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm’s revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the business posted $6.26 EPS. Analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were given a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is currently 45.97%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.